Scienture Holdings SCNX
NASDAQ SCNX
$3.05 +0.13 (+4.27%)
As of: Oct 20, 2026 · 3:53 PM EDT

Scienture Holdings (SCNX) Current Deferred Revenue (2020 - 2022)

Updated

Scienture Holdings' Current Deferred Revenue came in at $996.00 for Q1 2022, down 90.0% from $10,000 a year earlier.

Analysis

Scienture Holdings (SCNX) Current Deferred Revenue (2020 - 2022) Analysis & Trends

At the end of FY2020, Scienture Holdings' Current Deferred Revenue was $10,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Scienture Holdings 4.83 Mn -12.09 Mn 335,779.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 996.00
Mar 31, 2021 10,000.00
Dec 31, 2020 10,000.00
Jun 30, 2020 3,574.00
Mar 31, 2020 305,972.00
API Access

Scienture Holdings Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SCNX&period=max&api_key=YOUR_API_KEY